Cargando…

Matrix Metalloproteinase Expression Patterns in Luminal A Type Breast Carcinomas

Objective: Aberrant expression of individual matrix metalloproteinases has been associated with poor prognosis in various human carcinomas. The current study aimed at defining an RNA expression profile of various MMPs in breast cancer and correlating their expression with clinicopathological paramet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Decock, J., Hendrickx, W., Drijkoningen, M., Wildiers, H., Neven, P., Smeets, A., Paridaens, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2007
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851059/ https://www.ncbi.nlm.nih.gov/pubmed/17473389 http://dx.doi.org/10.1155/2007/281727

Ejemplares similares

Expression of Matrix Metalloproteinases in Human Breast Cancer Tissues
por: Benson, Chellakkan Selvanesan, et al.
Publicado: (2013)

Short-Term Prognostic Index for Breast Cancer: NPI or Lpi
por: Van Belle, V., et al.
Publicado: (2010)

Blood Immunosenescence Signatures Reflecting Age, Frailty and Tumor Immune Infiltrate in Patients with Early Luminal Breast Cancer
por: Berben, Lieze, et al.
Publicado: (2021)

Plasma MMP1, MMP8 and MMP13 expression in breast cancer: protective role of MMP8 against lymph node metastasis
por: Decock, J, et al.
Publicado: (2008)

Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors
por: Lambrechts, Yentl, et al.
Publicado: (2023)

Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer
por: Berben, Lieze, et al.
Publicado: (2020)

Matrix Metalloproteinase-2, Squamous Cell Carcinoma Antigen, and Tissue Polypeptide-Specific Antigen Expression in Egyptian Patients with Cervical Carcinoma: Relationship with Prognosis
por: Ahmed, Maha Imam, et al.
Publicado: (2004)

Matrix metalloproteinases: protective roles in cancer
por: Decock, Julie, et al.
Publicado: (2011)

Matrix Metalloproteinase 8 (Collagenase 2) Induces the Expression of Interleukins 6 and 8 in Breast Cancer Cells
por: Thirkettle, Sally, et al.
Publicado: (2013)

Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice
por: Decock, Julie, et al.
Publicado: (2015)

Abnormal Expression of Matrix Metalloproteinase-9 (MMP9) Correlates with Clinical Course in Chinese Patients with Endometrial Cancer
por: Yu, Fang, et al.
Publicado: (2012)

Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast Carcinomas
por: Iwata, Hiroji, et al.
Publicado: (1996)

Plasma MMP1 and MMP8 expression in breast cancer: Protective role of MMP8 against lymph node metastasis
por: Decock, Julie, et al.
Publicado: (2008)

Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?
por: Smeets, Ann, et al.
Publicado: (2013)

Significance of Membrane Type 1 Matrix Metalloproteinase Expression in Breast Cancer
por: Ishigaki, Shinsuke, et al.
Publicado: (1999)

Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer
por: Lambrechts, Yentl, et al.
Publicado: (2023)

Matrix Metalloproteinase 13 Genotype in rs640198 Polymorphism Is Associated with Severe Coronary Artery Disease
por: Vašků, Anna, et al.
Publicado: (2012)

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis
por: Wang, Ji, et al.
Publicado: (2017)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Bladder Cancer Risk Associated with Genotypic Polymorphism of the Matrix Metalloproteinase-1 and 7 in North Indian Population
por: Srivastava, Priyanka, et al.
Publicado: (2010)

Matrix metalloproteinases in keratinocyte carcinomas
por: Riihilä, Pilvi, et al.
Publicado: (2020)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma
por: Qiao, Zhen-kui, et al.
Publicado: (2013)

The Value of Combined Use of Survivin mRNA and Matrix Metalloproteinase 2 and 9 for Bladder Cancer Detection in Voided Urine
por: Eissa, Sanaa, et al.
Publicado: (2013)

Matrix Metalloproteinase Activity in Gingival Crevicular Fluid and Periodontal Health Status in Down Syndrome Patients: A Comparative Study
por: Ahmed, Nizar, et al.
Publicado: (2023)

Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
por: Hur, J. H., et al.
Publicado: (2000)

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015)

Shedding of Membrane Type 1 Matrix Metalloproteinase in a Human Breast Carcinoma Cell Line
por: Harayama, Takeshi, et al.
Publicado: (1999)

The luminous and the grey
por: Batchelor, David
Publicado: (2014)

Expression levels of matrix metalloproteinase-9 in human gastric carcinoma
por: CHEN, SU-ZUAN, et al.
Publicado: (2015)

Expression of Matrix Metalloproteinase-21 in Oral Squamous Cell Carcinoma
por: Baskaran, Adhithya, et al.
Publicado: (2023)

Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
por: De Cock, L., et al.
Publicado: (2021)

Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines
por: Schröpfer, Andrea, et al.
Publicado: (2010)

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
por: Talvensaari-Mattila, A, et al.
Publicado: (2003)

The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma
por: LU, HONGSHENG, et al.
Publicado: (2013)

Association of MMP8 gene variation with breast cancer prognosis
por: Decock, J, et al.
Publicado: (2008)

Coordinated elevation of membrane type 1-matrix metalloproteinase and matrix metalloproteinase-2 expression in rat uterus during postpartum involution
por: Manase, Kengo, et al.
Publicado: (2006)

Prognostic Value of Lymphangiogenesis Determinants in Luminal and Non-luminal Breast Carcinomas
por: Widodo, Irianiwati, et al.
Publicado: (2018)

Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma
por: Kikuchi, R, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_84f0k6p69vp6uu488fha4rptne